Johnson & Johnson

This week's top stories include use of the J&J vaccine being halted due to rare, severe reactions, the Mayo Clinic launching a remote diagnostics platform, and an Omada tool that helps physical therapists virtually measure a patient's movement.

This week's top stories include a plea to increase efforts to collect ethnicity data when administering vaccinations, and Apple and the University of Michigan sharing the first results from the Apple Hearing Study.